![(3alpha,5beta,8xi,9xi)-3-[(2,6-dideoxy-3-O-methyl-beta-D-glycero-hexopyranosyl)oxy]-5,14-dihydroxycard-20(22)-enolide](https://static.cymitquimica.com/cas-image/388555-3alpha-5beta-8xi-9xi-3-26-dideoxy-3-o-methyl-beta-d-glycero-hexopyranosyl-oxy-514-dihydroxycard-20-22-enolide.png)
CAS: 32476-67-8 - (3alpha,5beta,8xi,9xi)-3-[(2,6-dideoxy-3-O-methyl-beta-D-glycero-hexopyranosyl)oxy]-5,14-dihydroxycard-20(22)-enolide
Fórmula:C30H46O8
InChI:InChI=1S/C30H46O8/c1-17-26(32)23(35-4)14-25(37-17)38-19-5-9-27(2)21-6-10-28(3)20(18-13-24(31)36-16-18)8-12-30(28,34)22(21)7-11-29(27,33)15-19/h13,17,19-23,25-26,32-34H,5-12,14-16H2,1-4H3/t17-,19+,20-,21+,22-,23+,25+,26-,27-,28-,29+,30+/m1/s1
Clave InChI:InChIKey=XRWQBDJPMXRDOQ-YUUDFPFBSA-N
SMILES:O=C1OCC(=C1)C2CCC3(O)C4CCC5(O)CC(OC6OC(C)C(O)C(OC)C6)CCC5(C)C4CCC23C
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Periplocymarin REF: 7W-GY8855CAS: 32476-67-8 | - - - | A consultar | Mar 07 May 24 |
 | Periplocymarin REF: BP-BP3656CAS: 32476-67-8 | 95%~99% | 165,00 €~675,00 € | Jue 09 May 24 |
 | Periplocymarin REF: TM-TN2054CAS: 32476-67-8 | 98.63% | 109,00 €~714,00 € | Lun 13 May 24 |
 | Periplocymarin REF: 3D-HBA47667CAS: 32476-67-8 | Min. 95% | A consultar | Lun 17 Jun 24 |
Ref: 7W-GY8855
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Martes 7 de Mayo de 2024
Ref: BP-BP3656
| 10mg | 165,00 € | |
| 20mg | 247,00 € | |
| 100mg | 675,00 € |
Entrega estimada en Estados Unidos, el Jueves 9 de Mayo de 2024
Periplocymarin
CAS:32476-67-8
Periplocymarin is a cardiac glycoside with anticancer potential isolated from Periploca sepium and Periploca graeca.
Fórmula:
C30H46O8
Pureza:
98.63%
Forma y color:
Solid
Peso molecular:
534.68
Ref: TM-TN2054
| 1mg | 109,00 € | |
| 2mg | 160,00 € | |
| 5mg | 250,00 € | |
| 10mg | 434,00 € | |
| 25mg | 714,00 € |
Entrega estimada en Estados Unidos, el Lunes 13 de Mayo de 2024
Periplocymarin
CAS:32476-67-8
Periplocymarin is a natural product that belongs to the group of cardiac pharmaceutical preparations. It …
Fórmula:
C30H46O8
Pureza:
Min. 95%
Peso molecular:
534.7 g/mol
Ref: 3D-HBA47667
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 17 de Junio de 2024
